Background: Chronic obstructive pulmonary disease (COPD) is the fourth cause of dead in the world. Because of high incidence of comorbidities in COPD patients, it has been proposed a new hypothesis that inscribe this disease in a complex contest named Chronic Systemic Inflammatory Syndrome (CSIS). Either COPD and the most common comorbidities responsible for its clinical and natural history, like hypertension, diabetes, coronary artery disease, heart failure, recognize a pro-inflammatory state, marked, for example, by elevated C reactive protein (CRP). Methods: 113 consecutive patients presenting to Emergency Department (ED) with acute exacerbated COPD were enrolled. They underwent to full medical history and physical examination. CRP was measured at ED arrival, discharge and at 1-6-12 month follow up. CSIS was diagnosed according to specified criteria. Results: CSIS was diagnosed in 84% patients. CRP was maximally increased at admission during the exacerbation, but didn't correlate with the severity of it. At discharge, CRP values were lowest; during follow up, CRP demonstrated a chaotic behavior growing up till 6 month without any correlation with new exacerbation events. At 1 year it decreased, never reaching normal values in the majority of our patients thus confirming the presence of a persistent inflammation in COPD. Conclusions: CSIS was diagnosed in 84% of our population demonstrating that COPD patients need to be approached in a multidisciplinary way.

Chronic Systemic Inflammatory Syndrome in patients with AECOPD presenting to Emergency Department / O., Piras; F., Travaglino; A., Autunno; E., Bresciani; A. D., Corte; I., Lalle; DI SOMMA, Salvatore. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - STAMPA. - 16:1(2012), pp. 57-61.

Chronic Systemic Inflammatory Syndrome in patients with AECOPD presenting to Emergency Department

DI SOMMA, Salvatore
2012

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is the fourth cause of dead in the world. Because of high incidence of comorbidities in COPD patients, it has been proposed a new hypothesis that inscribe this disease in a complex contest named Chronic Systemic Inflammatory Syndrome (CSIS). Either COPD and the most common comorbidities responsible for its clinical and natural history, like hypertension, diabetes, coronary artery disease, heart failure, recognize a pro-inflammatory state, marked, for example, by elevated C reactive protein (CRP). Methods: 113 consecutive patients presenting to Emergency Department (ED) with acute exacerbated COPD were enrolled. They underwent to full medical history and physical examination. CRP was measured at ED arrival, discharge and at 1-6-12 month follow up. CSIS was diagnosed according to specified criteria. Results: CSIS was diagnosed in 84% patients. CRP was maximally increased at admission during the exacerbation, but didn't correlate with the severity of it. At discharge, CRP values were lowest; during follow up, CRP demonstrated a chaotic behavior growing up till 6 month without any correlation with new exacerbation events. At 1 year it decreased, never reaching normal values in the majority of our patients thus confirming the presence of a persistent inflammation in COPD. Conclusions: CSIS was diagnosed in 84% of our population demonstrating that COPD patients need to be approached in a multidisciplinary way.
2012
80 and over; acute disease; acute exacerbation; adult; aged; analysis; c-reactive protein; chronic obstructive; chronic systemic inflammatory syndrome; comorbidity; complications/epidemiology; copd; diabetes complications; emergency medical services; emergency service; epidemiology; epidemiology/therapy; female; follow-up studies; heart diseases; hospital; humans; lung; male; middle aged; obesity; pathology; pulmonary disease; smoking; treatment outcome
01 Pubblicazione su rivista::01a Articolo in rivista
Chronic Systemic Inflammatory Syndrome in patients with AECOPD presenting to Emergency Department / O., Piras; F., Travaglino; A., Autunno; E., Bresciani; A. D., Corte; I., Lalle; DI SOMMA, Salvatore. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - STAMPA. - 16:1(2012), pp. 57-61.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/471432
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact